Skip to content

Advertisement

  • Original article
  • Open Access

New bioactive metabolites from the elicited marine sponge-derived bacterium Actinokineospora spheciospongiae sp. nov.

  • 1, 2,
  • 3,
  • 3,
  • 4,
  • 4,
  • 5Email author,
  • 1 and
  • 3Email author
AMB Express20199:12

https://doi.org/10.1186/s13568-018-0730-0

  • Received: 21 December 2018
  • Accepted: 31 December 2018
  • Published:

Abstract

Several approaches have been dedicated to activate the cryptic gene clusters in the genomes of actinomycetes for the targeted discovery of new fascinating biomedical lead structures. In the current study, N-acetylglucosamine was used to maximize the chemical diversity of sponge-derived actinomycete Actinokineospora spheciospongiae sp. nov. HR–ESI–MS was employed for dereplication study and orthogonal partial least square-discriminant analysis was applied to evaluate the HR–ESI–MS data of the different fractions. As a result, two new fridamycins H (1) and I (2), along with three known compounds actinosporin C (3), D (4), and G (5) were isolated from the solid culture of sponge-associated actinomycete Actinokineospora spheciospongiae sp. nov., elicited with N-acetylglucosamine. Characterization of the isolated compounds was pursued using mass spectrometry and NMR spectral data. Fridamycin H (1) exhibited significant growth inhibitory activity towards Trypanosoma brucei strain TC221. These results highlight the potential of elicitation in sponge-associated actinomycetes as an effective strategy for the discovery of new anti-infective natural products.

Keywords

  • Sponges
  • Actinomycetes
  • Actinokineospora
  • Fridamycin
  • Elicitation
  • Antitrypanosomal

Introduction

Marine sponge-derived actinomycetes have been recognized as potential producers of fascinating chemical scaffolds such as polyketides, alkaloids, peptides, sterols, terpenes and fatty acids (Abdelmohsen et al. 2014a, c; Genilloud 2017; Ibrahim et al. 2018; Van der Meij et al. 2017) with diverse pharmacological activities such as antichlamydial, antioxidant, antibacterial, antitrypanosomal, cytotoxic, and antibiofilm (Abdelmohsen et al. 2017; Balasubramanian et al. 2017; Cheng et al. 2015, 2017). The strain Actinokineospora spheciospongiae was first isolated by Abdelmohsen et al. in 2010 from the Red Sea sponge Spheciospongia vagabunda that was collected from Ras Mohamed, Egypt (Abdelmohsen et al. 2010). The strain was then described by Kampfer et al. in 2015 and the draft genome sequence was analysed (Harjes et al. 2014; Kampfer et al. 2015). The chemical and biological investigation of this strain emphasized the diversity of its natural components and resulted in identification of several new natural products (Abdelmohsen et al. 2014b; Dashti et al. 2017). Actinomycetes have been found to have the major fraction of their secondary metabolites to be transcriptionally inactive or “silent” under normal laboratory conditions (Abdelmohsen et al. 2015; Dinesh et al. 2017; Horn et al. 2015; Letzel et al. 2017; Seyedsayamdost 2014). In a study by Letzel et al. (2017), analysis of genome sequences of 119 marine actinomycetes reveals extraordinary biosynthetic diversity. Several experimental approaches have been applied to activate and identify the products of those cryptic genes using biological, chemical and genetic elicitations (Abdelmohsen et al. 2015; Dashti et al. 2017; Pettit 2011). In our previous work, Actinokineospora spheciospongiae broth culture was elicited with N-acetyl glucosamine (GlcNAc) and the metabolic profile was investigated using 1H NMR fingerprint methodology which resulted in identification of four new actinosporins (E–H) (Dashti et al. 2017). In the present study, the solid culture of Actinokineospora spheciospongiae sp. nov. was elicited with GlcNAc that led to the identification of two new fridamycins (1 and 2), along with three known compounds actinosporin C (3), D (4), and G (5). Moreover, the antitrypanosomal activity of all isolated pure compounds was also investigated.

Materials and methods

Microbial fermentation, extract preparation and compounds isolation

Actinokineospora spheciospongiae sp. nov. (DSM 45935T, GeneBank accession no. GU318361) was isolated from the Red Sea sponge Spheciospongia vagabunda that was collected by SCUBA diving from offshore Ras Mohamed, Egypt (GPS: 27°47.655 N; 34°12.904 W) in August 2006. Two hundred ISP2 agar plates (square 120 × 120 mm), each inoculated with 100 µL of a 5 day old liquid culture of Actinokineospora spheciospongiae and incubated at 30 °C for 6 h. The agar plates were then elicited with GlcNAc (50 µL/plate of a 50 μM solution, Sigma-Aldrich, Darmstadt, Germany). The plates were then incubated at 30 °C for 7 days. The agar medium with bacterial biomass was cut into small pieces and transferred to 1 L Erlenmeyer flasks. One liter of EtOAc/flask was added to submerge the agar pieces and macerate the medium culture under shaking at 150 rpm for overnight. The macerated medium was subsequently filtered using filter paper (A. Hartenstein, Wurzburg, Germany). The filtrates were combined and evaporated in a rotary evaporator under vacuum (Büchi, Essen, Germany) to yield 850 mg of dried crude EtOAc extract, which was fractionated on a Sephadex LH20 (50 g, 32–64 µm, 100 × 10 mm, Merck, Darmstadt, Germany) column eluting with H2O/MeOH (90:10%) to 100% methanol, to yield 12 fractions (50 mL each). The highly active fractions (3 and 5) were further purified by semi-preparative HPLC (Agilent, Waldbronn, Germany) using H2O/acetonitrile (95:5%) initially for 5 min, followed by a linear gradient to 100% acetonitrile within 40 min and maintained isocratically for further 5 min. Separation was achieved on a preparative C18 column (5 µm, 10 × 250 mm, Waters XBridge, Eschborn, Germany), with a flow rate of 3.0 mL/min yielding compounds 1 (1.6 mg) and 2 (1.8 mg) from fraction 3 and compounds 35 (2.3, 2.5 and 3 mg, respectively) from fraction 5.

LC–MS analysis

One milligram of dried microbial extracts and/or fractions was dissolved in HPLC-grade MeOH to a final concentration of 1 mg/mL and subjected to high resolution LC–ESI–MS using Thermo Scientific Exact mass analysers (Thermo Scientific, Karlsruhe, Germany) coupled to a Dionex UltiMate 3000 HPLC system. The samples were eluted through a C-18 column (ACE, Mainz, Germany) with a length of 75 mm, internal diameter of 3.0 mm and particle size 5 μm. The mobile phase consisted of 0.1% formic acid in HPLC-grade water (solvent A) and acetonitrile (solvent B). The flow rate was set at 300 µL/min. Gradient elution was initiated with 10% B for 5 min, which was increased to 100% B over 30 min, which was maintained for another 5 min before decreasing to 10% B in the next min. The column was then equilibrated with 10% B for 4 min until the end of the run. MS/MS was measured using LTQ Orbitrap Thermo scientific mass analysers (Thermo Scientific, Karlsruhe, Germany).

Biological activity of the isolated compounds

Antitrypanosomal activity

Antitrypanosomal action had been investigated following the method reported by Abdelmohsen et al. (2014b). In brief, Complete Baltz Medium was used for cultivation of 104 trypanosomes per mL of the Trypanosoma brucei strain TC 221 (Missionsärztliche Klinik, University of Wurzburg). 96-well plate chambers were used for testing Trypanosomes versus various concentrations of examined compounds at 0.25–40 μM in DMSO (1%) to a final volume of 200 μL. For controls, DMSO (1%) plus parasites without any examined compound were used concurrently in each plate. After that, the plates were incubated in an atmosphere of CO2 5% at 37 °C for 24 h. Then, 20 μL of Alamar Blue was added in each plate and the activity was measured by light absorption at ʎ 550 nm with a reference wavelength of 650 nm using an MR 700 Microplate Reader (Dynatech Engineering Ltd., Willenhall, UK) after 48 and 72 h. The quantification of the IC50 values of the examined compounds were processed by linear interpolation in triplicate.

Cytotoxicity activity

Macrophages (J774.1) (Missionsärztliche Klinik, University of Wurzburg) were cultivated in Complete Baltz Medium free from phenol red. Different concentrations of tested compounds (0.25–200 μM) at a cell density of 1 × 105 cells/mL at 37 °C, 5% CO2, and 95% humidity for 24 h, were used for investigation of their cytotoxic properties against Macrophages (J774.1). After adding of Alamar Blue (20 μL), the plates were incubated and the then, determination of the optical densities at ʎ 540 nm and a reference wavelength of 630 nm were done after 48 and 72 h, in the same way as described for the anti-trypansomal activity (Abdelmohsen et al. 2014b).

Compounds characterization

Fridamycin H (1): Orange powder; [α] D 25  + 12° (c 1.5, MeOH); UV (MeOH) λ max (log ε) 231 (4.45), 253 (4.51), 293 (4.37) nm; IR (KBr)νmax 3420, 2962, 1710, 1436, 1340, 1275, 1065 cm−1; 1H NMR (DMSO-d6, 600 MHz) and 13C NMR (DMSO-d6, 150 MHz) data, see Table 2; HR-ESIMS (+) m/z 503.1524 [M+H]+ (calcd. for C25H26O11, 503.1553).

Fridamycin I (2): Yellow powder; [α] D 25  + 25° (c 1.5, MeOH); UV (MeOH) λ max (log ε) 232 (4.54), 253 (4.53), 294 (4.17) nm; IR (KBr)νmax 3419, 3030, 1700, 1650, 1432, 1345, 1275, 1065 cm−1; 1H NMR (DMSO-d6, 600 MHz) and 13C NMR (DMSO-d6, 150 MHz) data, see Table 3; HR-ESIMS (+) m/z 614.2036 [M+Na]+ (calcd. for C32H33NO10Na, 614.2021).

Results

Bioactivity-guided assay and metabolomic analysis

All fractions were subjected to HPLC-HR-ESIMS analysis on both negative and positive ionization switch modes to cover the maximum number of metabolites. The MS dataset was processed and data were extracted using MZmine 2.20 based on the established parameters (Tawfike et al. 2017). The dereplication study of the active fractions against DNP database revealed the presence of known metabolites, but mostly unknown hits dominated as shown in Table 1. Metabolites at m/z (retention time in minutes) 387.0865 (6.65) [M−H] and 401.1025 (10.44) [M−H], were dereplicated as G-2N (C23H16O6), an antibiotic formerly reported from actinomycete Frankia sp.(Nancy and Mary 1984), and saptomycin F (C24H18O6), an antibiotic previously isolated from Streptomyces sp.(Abe et al. 1993), respectively. The aforementioned dereplicated metabolites, depicted in Fig. 1, possessed the naphthacene-dione moiety. Additionally, the mass ion peak at m/z 227.175 [M+H]+ for the predicted molecular formula C12H22N2O2 was dereplicated as isoleucyl isoleucine anhydride. The latter is a dipeptide previously reported from Ustilago cynodontis and Beauveria bassiana (Geraci et al. 2000).
Table 1

The dereplication results of the active fractions against DNP database

Polarity

m/z

Rt

Formula

Name

Source

[M−H]

387.0865

6.65

C23H16O6

G-2N

Frankia sp. ANP 190107

[M+H]+

188.1279

7.69

C9H17NO3

Unknown

[M−H]

343.0952

8.67

C18H12N6O2

Unknown

[M+H]+

227.1753

9.00

C12H22N2O2

Isoleucyl isoleucine anhydride

Ustilago cynodontis, Beauveria bassiana

[M−H]

369.0751

9.84

C19H10N6O3

Unknown

[M−H]

1003.325

9.86

Complex of 501.1586 and 501.1586 m/z

[M−H]

501.1586

9.86

C31H18N8

Unknown

[M+H]+

357.097

9.88

C19H16O7

Fridamycin E

Streptomyces parvulus Tu 1989

[M−H]

401.1025

10.44

C24H18O6

Saptomycin-F

Streptomyces strain HP530

[M+H]+

357.0968

15.66

C16H8N10O

Unknown

[M−H]

355.0954

15.67

C19H12N6O2

Unknown

Fig. 1
Fig. 1

Dereplicated structures from the active fractions: G-2N and saptomycin F

The dereplication results highlighted the previously reported active compounds that would guide the structure elucidation of the isolated unknown metabolites. Multivariate data analysis (MVDA) was performed for the MS dataset of active versus inactive fractions to pinpoint the putatively active metabolites in the antitrypanosomally-active fractions prior to any further purification attempts.

To achieve the best discrimination between the active and inactive fractions, a supervised orthogonal partial least square discriminant analysis (OPLS-DA) was carried out. The OPLS-DA scores plot (Fig. 2a) showed a significant discrimination between active and inactive fractions revealing a regression fit of 99% (R2 = 0.99) and high predictive ability of Q2 = 0.96. The current OPLS-DA model produced the highest predictive power (Q2) when assessed by cross validation. Moreover, the statistical significance of estimated predictive power of the respective model was tested by permutation test which exhibited Q2Y intercept at − 0.81 that indicated a valid model. A particularly useful tool that compares the variable magnitude against its reliability is the S-loadings plot obtained from the OPLS-DA model and represented in Fig. 2b, where axes plotted from the predictive component are the covariance p[1] against the correlation p (cor) [1]. The S-loadings plot highlighted the metabolites distinct for the active fractions that highly correlated to their bioactivity.
Fig. 2
Fig. 2

a OPLS-DA score plot of active (red circle) versus inactive fractions (yellow circle). b S-loading plot showing the putatively active metabolites

The metabolite at m/z 501.159 (Rt = 9.86 min) [M−H], equivalent to C25H26O11 did not match any compounds reported in the DNP database while the m/z ion at 357.097 (Rt = 9.88 min) [M+H]+ for the predicted molecular formula C19H16O7 was dereplicated for fridamycin E, the simplest member of the angucycline family of antibiotics that was previously isolated from a mutant of Streptomyces parvulus (strain Tu 1989) (Krohn and Baltus 1988; Kunzel et al. 1999). The metabolomics and dereplication results (Table 1, Fig. 1) revealed previously undescribed putatively active metabolites that motivated us to further purify the fractions and identify the active compounds via 1D, 2D-NMR and HR–ESIMS.

Structure elucidation of the new isolated compounds

Separation of fraction 3 delivered two hydroxyquinones with similar UV spectra (231, 253, 293 nm) indicating similar chromophores. A molecular formula of C25H26O11 was established for 1 (Fig. 3) by positive HR-ESIMS analysis (found at m/z 503.1524 for [M+H]+, calcd. 503.1553) requiring thirteen degrees of unsaturation (Additional file 1: Figure S1). The 600 MHz instrument for 1H, 13C, COSY, HSQC and HMBC (optimized for J = 8.3 Hz and J = 4.0 Hz) in DMSO-d6 was used for processing the NMR spectral analyses. Initial investigation of NMR spectral data of 1 (Table 2) exhibited characteristic signals for a C-4 substituted (R)-fridamycin E moiety (Krohn and Baltus 1988; Myronovskyi et al. 2016; Vicente et al. 2015).
Fig. 3
Fig. 3

Structures of the isolated compounds: fridamycin H (1) and I (2), actinosprin C (3), D (4) and G (5)

Table 2

1H and 13C NMR data (DMSO-d6, 600 and 150 MHz) of 1

Position

δH, mult (J in Hz)

δC, type

COSY

HMBC

1

7.95, d (7.8)

120.6, CH

H-2

C-3, 10

2

7.86, dd (7.8, 8.4)

135.4, CH

H-1, 3

C-4, 10a

3

7.70, d (8.4)

123.6, CH

H-2

C-1, 4a

4

156.8, C

4a

122.3, C

5

181.2, C

5a

133.4, C

6

7.61, d (7.8)

118.2, CH

H-7

C-8, 9a, 5

7

7.78, d (7.8)

141.0, CH

H-6

C-5a, 9

8

133.4, C

9

160.3, C

9a

115.1, C

10

188.9, C

10a

135.2, C

11a

11b

2.88, d (13.2)

3.03, d (13.2)

40.1, CH2

C-7, 9

12

71.5, C

13

2.40, s

46.7, CH2

C-11

14

172.8, C

15

1.19, s

26.8, CH3

C-11, 13

1′

5.64, d (1.8)

99.3, CH

H-2′

C-4′, 5′

2′

3.99, m

70.5, CH

H-1′

C-1′

3′

3.99, m

70.5, CH

H-4′

4′

3.33, m

72.0, CH

H-3′

5′

3.52, m

70.4, CH

H-4′, 6′

6′

1.09, d (6)

18.4, CH3

H-5′

C-5′, 4′

The aromatic region in 1H NMR spectrum (Additional file 1: Figure S2) displayed the presence of two different aromatic spin systems of ortho-coupled protons; one corresponds to a tri-substituted benzene ring consisting of two one-proton doublets at δH 7.95 (J = 7.8 Hz) and 7.70 (J = 8.4 Hz) assignable to H-1 and H-3, respectively, in addition to a one proton doublet of doublet at δH 7.86 (J = 7.8 and 8.4 Hz), of H-2. Another spin system consists of two one-proton doublets at δH 7.78 (J = 7.8 Hz) and 7.61 (J = 7.8 Hz) assignable to protons H-6 and H-7, respectively, of the tetra-substituted aromatic system. Moreover, the 1H NMR spectrum showed two one-proton doublets at δH 2.88 (J = 13.2 Hz) and 3.03 (J = 13.2 Hz), attributed to the two geminally coupled protons, characteristic for H-11a and H-11b, respectively. Whereas, the two-protons singlet at δH 2.40 was assignable for H-13, belonging to the protons of a methylene group directly linked to the carboxyl group. One singlet at δH 1.19 together with its corresponding carbon signal at δC 26.8 was for the methyl group (CH3-15) which was considerably downfield shifted due to its direct attachment to oxygenated carbon at δC 71.5 (C-12) (Vicente et al. 2015). Moreover, the presence of an anomeric proton signal at δH 5.64 (J = 1.8 Hz; δC 99.3), one methyl doublet at δH 1.09 (J = 6 Hz), as well as four one-proton multiplets at δH (3.33–3.99) indicated the presence of the rhamnose moiety in the structure (Grkovic et al. 2014). The coupling constant of the anomeric proton allowed the identification of an α anomer and the absolute configuration of sugar was determined to be L based on the literature (Dashti et al. 2017).

The 13C NMR and HSQC spectra (Additional file 1: Figures S3, S5) displayed fourteen resonances comprising five methine sp2, five methine sp3, two methylene sp3, two methyl carbons consistent with an angucycline core and one glycosidic residue. Three carbonyl carbons were displayed, the upfield shifted carbon at δC 172.8 was attributed to free carboxyl group (C-14), while the others resonated at δC 181.2 and 188.9 were assigned to quinone carbonyl carbons C-5 and C-10, respectively. Additionally two methylene carbons C-11 and C-13 were observed; the latter was deshielded to 46.7 ppm in agreement with direct attachment to carboxylic group, while the former one was detected at 40.1 ppm due to its direct attachment to the aromatic ring that could be confirmed by HMBC correlations from H-11a and H-11b (δH 2.88 and 3.03) to C-7 (δC 141.0) and C-9 (δC 160.3). Two oxygenated aromatic carbons were observed at δC 156.8 and 160.3, assignable to C-4 and C-9, respectively. The former (C-4) displayed HMBC correlation to the anomeric proton of l-rhamnose (δH 5.64, H-1′), confirming the attachment of l-rhamnose to C-4 of the anthraquinone motif (Fig. 4). Due to a small amount of 1 obtained in this study, it was not possible to determine the absolute configuration of C-12. However, as 1 is a 4-O-glycosylated fridamycin E, we speculated that the absolute configuration of C-12 of 1 should be the same as that of naturally occurring fridamycin E (Krohn and Baltus 1988) i.e. 12R. However, it is necessary to obtain more amount of 1 to determine conclusively the absolute configuration of C-12. As a common biosynthesis feature of Streptomyces sp., all the naturally identified fridamycin E analogues retain the (R) configuration (α-OH and β-CH3) at C-12. Whereas the (S) isomers, (α-CH3 and β-OH) at C-12, have been only obtained chemosynthetically as the less bioactive isomers of fridamycin E analogues (Bruntner et al. 2005; Chen et al. 2011; Rohr and Thiericke 1992; Vicente et al. 2015).
Fig. 4
Fig. 4

Key COSY and HMBC correlations of fridamycin H (1) and I (2)

COSY, HSQC and HMBC experiments (Additional file 1: Figures S4–S6) were used to support the aforementioned assignments and the structure of 1, which was a new compound that we named fridamycin H.

HR-ESIMS of 2 (Fig. 3) established the molecular formula as C32H33NO10Na (found at m/z 614.2036, calcd. 614.2021) [M+Na]+) requiring seventeen degrees of unsaturation Additional file 1: Figure S7). First investigation of the NMR spectroscopic data of 2 (Table 3) (Additional file 1: Figures S8–S12) showed many signals similar to chemical shifts of those reported for 1 (fridamycin H) except for the substitution of the carboxyl group of 1 with N-benzyl amide moiety that was represented by multiplet signals at δH 7.25, 7.30 and 7.24 assignable to (H-2″, 6″), (H-3″, 5″) and H-4″, respectively, in accordance with mono-substituted benzene ring. Two-protons singlet at δH 3.54 along with its corresponding carbon signal at δC 40.9 were for the methylene group (CH2-16) directly attached to the benzene ring and one singlet at δH 8.17 corresponding to an amine proton (Myronovskyi et al. 2016). Moreover, HMBC correlations from H-16 (δH 3.54) to C-1″ and C-2″, 6″ at δC 135.45 and 129.7, respectively and to amide-type carbonyl carbon at (δC 173.2) were observed confirming direct attachment of the methylene group (CH2-16) to the benzene ring from one side and to the amide moiety from the other side (Myronovskyi et al. 2016) (Fig. 4).
Table 3

1H and 13C NMR data (DMSO-d6, 600 and 150 MHz) of 2

Position

δH, mult (J in Hz)

δC, type

COSY

HMBC

1

7.95, d (7.8)

120.6, CH

H-2

C-3, 4a, 10

2

7.85, dd (7.8, 8.4)

135.5, CH

H-1, 3

C-4, 10a

3

7.70, d (8.4)

123.8, CH

H-2

C-1, 4a

4

156.7, C

4a

122.1, C

5

180.8, C

5a

133.35, C

6

7.61, d (7.8)

118.3, CH

H-7

C-8, 9a, 5

7

7.79, d (7.8)

140.3, CH

H-6

C5a, 9, 11

8

133.2, C

9

160.3, C

9a

115.1, C

10

189.0, C

10a

135.3, C

11a

11b

2.88, d (13.2)

3.03, d (13.2)

39.9, CH

C-7, 9, 13, 15

12

71.4, C

13

2.39, s

46.6, CH2

C-11, 15

14

173.2, C

15

1.18, s

26.5, CH3

C-11, 13

16

3.54, s

40.9, CH2

C-14, 1″, 2″, 6″

1′

5.64, d (1.8)

99.0, CH

H-2′

C-4, 5″

2′

3.99, m

70.4, CH

H-1′

C-1″

3′

3.99, m

70.5, CH

H-4′

4′

3.33, m

72.0, CH

H-3′

5′

3.52 m

70.6, CH

H-4′, 6′

6′

1.08, d (6)

18.2, CH3

H-5′

C-5″, 4″

1″

135.5, C

2″, 6″

7.25, m

129.7, CH

H-3″, 5″

3″, 5″

7.30, m

128.7, CH

H-2″, 6″

4″

7.24 m

127.0, CH

14-NH

8.17 br s

COSY, HSQC and HMBC experiments (Additional file 1: Figures S10–S12) were used to support the aforementioned assignments and the structure of compound 2, which was a new compound that we named fridamycin I.

Separation of fraction 5 delivered three actinosporins with similar UV spectra (250, 270, and 320 nm). By comparing their spectra (Additional file 1: Figures S13–S21) with previously published data (Dashti et al. 2017; Grkovic et al. 2014), the structures of these compounds were confirmed as actinosporin C (3), D (4) and G (5).

Biological activity of the isolated compounds

All the isolated compounds were tested against Trypanosoma brucei strain TC221 (Abdelmohsen et al. 2014b; Huber and Koella 1993). Compound 1 showed significant antitrypanosomal activity after 48 and 72 h with IC50 values of 7.18 and 3.35 μM, respectively, with no cytotoxicity against J774.1 macrophages (IC50 of > 200 μM). While the rest displayed no significant antitypanosomal or cytotoxic activity at the concentration tested.

Discussion

Bioinformatic analyses have revealed the presence of large fractions of silent gene clusters in the genome sequences of actinomycetes. Innovative strategies had been used to induce production of weakly expressed secondary metabolites which are not expressed under standard fermentation conditions and several approaches including biological, chemical, and molecular, have been applied to activate those silent natural products in the laboratory culture of actinomycetes (Abdelmohsen et al. 2015). Among those approaches, OSMAC approach (one strain many compounds), co-cultivation and applying of external chemical elicitors (Romano et al. 2018). In our previous studies the genome sequences (Harjes et al. 2014) as well as metabolomic analyses (Abdelmohsen et al. 2014b) of Actinokineospora spheciospongiae sp. nov. showed unexplored chemical potential. Actinosporins A and B had been isolated using broth culture of Actinokineospora sp. strain EG49 (Abdelmohsen et al. 2014b), while supplementing the same culture with calcium alginate beads allowed identification of actinosporins C and D have been identified (Grkovic et al. 2014). Moreover, induction of liquid culture of Actinokineospora sp. EG49 with GlcNAc has resulted in the isolation of and characterization of actinosporins E–H (Dashti et al. 2017). In the current approach, elicitation of the solid culture of Actinokineospora spheciospongiae sp. nov. via GlcNAc resulted in isolation and characterization of two new fridamycins H (1) and I (2), along with three known actinosporins C (3), D (4) and G (5).

On the other side, trypanosomiasis, commonly known as sleeping sickness, still has been considered one of the most serious challenges to human health, particularly in underdeveloped regions of Africa (Jacobs et al. 2011; Malvy and Chappuis 2011). It is commonly combined with degradation of hepatic cells, anemia and glomerulonephritis which are likely ascribed to considerable free radicals produced by the parasites which attack cellular membrane, leading to cellular damages of human vital organs. So far, effective antitrypanosomally drugs are still not accessible, regardless the extensive efforts to achieve treatments (Ibrahim et al. 2013; Steverding 2010). Thus, ongoing research for new classes of metabolites with antitrypanosomal activity is necessary. Consequently, two new fridamycins H (1) and I (2), along with three known actinosporins C (3), D (4) and G (5) were considered for the examination of the antitrypanosomal property versus Trypanosoma brucei TC221 in addition to cytototoxic properties towards Macrophages (J774.1). The results obtained displayed that fridamycin H showed significant antitrypanosomal activity after 48 and 72 h with IC50 values of 3.38 and 5.26 μM, respectively, with no cytotoxicity against J774.1 macrophages (IC50 > 200 μM). These results demonstrate the potential of elicitation via compound induction as a tool for discovery of new antitrypanosomal chemical scaffolds.

Declarations

Authors’ contributions

Conceptualization, URA; Formal analysis, AT, RE-E and URA; Investigation, AT, EZA, SYD, DH and AAM; Supervision, RE-E and URA; Writing-original draft, AT, EZA and SYD; Writing-review and editing, PJS, RE-E and URA. All authors read and approved the final manuscript.

Acknowledgements

We thank Vera Thoss for laboratory support and A. Stisch for antitrypanosomal activity testing.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Funding

This research received no external funding.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Computational and Analytical Science Department, Rothamsted Research, AL5 2JQ Harpenden, UK
(2)
Department of Pharmacognosy, Faculty of Pharmacy, Helwan University, Cairo, 11795, Egypt
(3)
Department of Pharmacognosy, Faculty of Pharmacy, Minia University, Minia, 61519, Egypt
(4)
Department of Biochemistry, Faculty of Science, Center for Science and Medical Research, University of Jeddah, 80203 Jeddah, Saudi Arabia
(5)
Carl-von-Ossietzky University Oldenburg, Institute for Chemistry and Biology of the Marine Environment, Postfach 2503, 26111 Oldenburg, Germany

References

  1. Abdelmohsen UR, Pimentel-Elardo SM, Hanora A, Radwan M, Abou-El-Ela SH, Ahmed S, Hentschel U (2010) Isolation, phylogenetic analysis and anti-infective activity screening of marine sponge-associated actinomycetes. Mar Drugs 8(3):399–412. https://doi.org/10.3390/md8030399 View ArticlePubMedPubMed CentralGoogle Scholar
  2. Abdelmohsen UR, Bayer K, Hentschel U (2014a) Diversity, abundance and natural products of marine sponge-associated actinomycetes. Nat Prod Rep 31(3):381–399. https://doi.org/10.1039/c3np70111e View ArticlePubMedGoogle Scholar
  3. Abdelmohsen UR, Cheng C, Viegelmann C, Zhang T, Grkovic T, Ahmed S, Quinn RJ, Hentschel U, Edrada-Ebel R (2014b) Dereplication strategies for targeted isolation of new antitrypanosomal actinosporins A and B from a marine sponge associated-Actinokineospora sp. EG49. Mar Drugs 12(3):1220–1244. https://doi.org/10.3390/md12031220 View ArticlePubMedPubMed CentralGoogle Scholar
  4. Abdelmohsen UR, Yang C, Horn H, Hajjar D, Ravasi T, Hentschel U (2014c) Actinomycetes from Red Sea sponges: sources for chemical and phylogenetic diversity. Mar Drugs 12(5):2771–2789. https://doi.org/10.3390/md12052771 View ArticlePubMedPubMed CentralGoogle Scholar
  5. Abdelmohsen UR, Grkovic T, Balasubramanian S, Kamel MS, Quinn RJ, Hentschel U (2015) Elicitation of secondary metabolism in actinomycetes. Biotechnol Adv 33(6 Pt 1):798–811. https://doi.org/10.1016/j.biotechadv.2015.06.003 View ArticlePubMedGoogle Scholar
  6. Abdelmohsen UR, Balasubramanian S, Oelschlaeger TA, Grkovic T, Pham NB, Quinn RJ, Hentschel U (2017) Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections. Lancet Infect Dis 17(2):e30–e41. https://doi.org/10.1016/S1473-3099(16)30323-1 View ArticlePubMedGoogle Scholar
  7. Abe N, Enoki N, Nakakita Y, Uchida H, Nakamura T, Munekata M (1993) Novel antitumor antibiotics, saptomycins. II. Isolation, physico-chemical properties and structure elucidation. J Antibiot (Tokyo) 46(10):1536–1549View ArticleGoogle Scholar
  8. Balasubramanian S, Othman EM, Kampik D, Stopper H, Hentschel U, Ziebuhr W, Oelschlaeger TA, Abdelmohsen UR (2017) Marine sponge-derived Streptomyces sp. SBT343 extract inhibits staphylococcal biofilm formation. Front Microbiol 8:236. https://doi.org/10.3389/fmicb.2017.00236 View ArticlePubMedPubMed CentralGoogle Scholar
  9. Bruntner C, Binder T, Pathom-aree W, Goodfellow M, Bull AT, Potterat O, Puder C, Horer S, Schmid A, Bolek W, Wagner K, Mihm G, Fiedler HP (2005) Frigocyclinone, a novel angucyclinone antibiotic produced by a Streptomyces griseus strain from antarctica. J Antibiot (Tokyo) 58(5):346–349. https://doi.org/10.1038/ja.2005.43 View ArticleGoogle Scholar
  10. Chen Q, Mulzer M, Shi P, Beuning PJ, Coates GW, O’Doherty GA (2011) De novo asymmetric synthesis of fridamycin E. Org Lett 13(24):6592–6595. https://doi.org/10.1021/ol203041b View ArticlePubMedPubMed CentralGoogle Scholar
  11. Cheng C, MacIntyre L, Abdelmohsen UR, Horn H, Polymenakou PN, Edrada-Ebel R, Hentschel U (2015) Biodiversity, anti-trypanosomal activity screening, and metabolomic profiling of actinomycetes isolated from mediterranean sponges. PLoS ONE 10(9):e0138528. https://doi.org/10.1371/journal.pone.0138528 View ArticlePubMedPubMed CentralGoogle Scholar
  12. Cheng C, Balasubramanian S, Fekete A, Krischke M, Mueller MJ, Hentschel U, Oelschlaeger TA, Abdelmohsen UR (2017) Inhibitory potential of strepthonium A against Shiga toxin production in enterohemorrhagic Escherichia coli (EHEC) strain EDL933. Nat Prod Res 31(23):2818–2823. https://doi.org/10.1080/14786419.2017.1297443 View ArticlePubMedGoogle Scholar
  13. Dashti Y, Grkovic T, Abdelmohsen UR, Hentschel U, Quinn RJ (2017) Actinomycete metabolome induction/suppression with N-acetylglucosamine. J Nat Prod 80(4):828–836. https://doi.org/10.1021/acs.jnatprod.6b00673 View ArticlePubMedGoogle Scholar
  14. Dinesh R, Srinivasan V, Anandaraj M, Srambikkal H (2017) Endophytic actinobacteria: diversity, secondary metabolism and mechanisms to unsilence biosynthetic gene clusters. Crit Rev Microbiol 43(5):546–566. https://doi.org/10.1080/1040841X.2016.1270895 View ArticlePubMedGoogle Scholar
  15. Genilloud O (2017) Actinomycetes: still a source of novel antibiotics. Nat Prod Rep 34(10):1203–1232. https://doi.org/10.1039/c7np00026j View ArticlePubMedGoogle Scholar
  16. Geraci C, Neri P, Paterno C, Rocco C, Tringali C (2000) An unusual nitrogenous terphenyl derivative from fruiting bodies of the basidiomycete Sarcodon leucopus. J Nat Prod 63(3):347–351View ArticleGoogle Scholar
  17. Grkovic T, Abdelmohsen UR, Othman EM, Stopper H, Edrada-Ebel R, Hentschel U, Quinn RJ (2014) Two new antioxidant actinosporin analogues from the calcium alginate beads culture of sponge-associated Actinokineospora sp. strain EG49. Bioorg Med Chem Lett 24(21):5089–5092. https://doi.org/10.1016/j.bmcl.2014.08.068 View ArticlePubMedGoogle Scholar
  18. Harjes J, Ryu T, Abdelmohsen UR, Moitinho-Silva L, Horn H, Ravasi T, Hentschel U (2014) Draft genome sequence of the antitrypanosomally active sponge-associated bacterium Actinokineospora sp. strain EG49. Genome Announc. https://doi.org/10.1128/genomea.00160-14 View ArticlePubMedPubMed CentralGoogle Scholar
  19. Horn H, Cheng C, Edrada-Ebel R, Hentschel U, Abdelmohsen UR (2015) Draft genome sequences of three chemically rich actinomycetes isolated from Mediterranean sponges. Mar Genomics 24(Pt 3):285–287. https://doi.org/10.1016/j.margen.2015.10.003 View ArticlePubMedGoogle Scholar
  20. Huber W, Koella JC (1993) A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites. Acta Trop 55(4):257–261View ArticleGoogle Scholar
  21. Ibrahim MA, Aliyu AB, Abdullahi H, Solomon T, Toko E, Garba A, Bashir M, Habila N (2013) Lactone-rich fraction from Vernonia blumeoides: antitrypanosomal activity and alleviation of the parasite-induced anemia and organ damage. J Nat Med 67(4):750–757. https://doi.org/10.1007/s11418-012-0737-9 View ArticlePubMedGoogle Scholar
  22. Ibrahim AH, Attia EZ, Hajjar D, Anany MA, Desoukey SY, Fouad MA, Kamel MS, Wajant H, Gulder TAM, Abdelmohsen UR (2018) New cytotoxic cyclic peptide from the marine sponge-associated Nocardiopsis sp. UR67. Mar Drugs 16:9. https://doi.org/10.3390/md16090290 View ArticleGoogle Scholar
  23. Jacobs RT, Nare B, Phillips MA (2011) State of the art in African trypanosome drug discovery. Curr Top Med Chem 11(10):1255–1274View ArticleGoogle Scholar
  24. Kampfer P, Glaeser SP, Busse HJ, Abdelmohsen UR, Ahmed S, Hentschel U (2015) Actinokineospora spheciospongiae sp. nov., isolated from the marine sponge Spheciospongia vagabunda. Int J Syst Evol Microbiol 65(Pt 3):879–884. https://doi.org/10.1099/ijs.0.000031 View ArticlePubMedGoogle Scholar
  25. Krohn K, Baltus W (1988) Synthesis of rac- and ent-Fridamycin E. Tetrahedron 44:49View ArticleGoogle Scholar
  26. Kunzel E, Faust B, Oelkers C, Weissbach U, Bearden DW, Weitnauer G, Westrich L, Bechthold A, Rohr J (1999) Inactivation of the urdGT2 gene, which encodes a glycosyltransferase responsible for the C-glycosyltransfer of activated d-olivose, leads to formation of the novel urdamycins I, J, and K. J Am Chem Soc 121:11058–11062View ArticleGoogle Scholar
  27. Letzel AC, Li J, Amos GCA, Millan-Aguinaga N, Ginigini J, Abdelmohsen UR, Gaudencio SP, Ziemert N, Moore BS, Jensen PR (2017) Genomic insights into specialized metabolism in the marine actinomycete Salinispora. Environ Microbiol 19(9):3660–3673. https://doi.org/10.1111/1462-2920.13867 View ArticlePubMedPubMed CentralGoogle Scholar
  28. Malvy D, Chappuis F (2011) Sleeping sickness. Clin Microbiol Infect 17(7):986–995. https://doi.org/10.1111/j.1469-0691.2011.03536.x View ArticlePubMedGoogle Scholar
  29. Myronovskyi M, Brotz E, Rosenkranzer B, Manderscheid N, Tokovenko B, Rebets Y, Luzhetskyy A (2016) Generation of new compounds through unbalanced transcription of landomycin A cluster. Appl Microbiol Biotechnol 100(21):9175–9186. https://doi.org/10.1007/s00253-016-7721-3 View ArticlePubMedGoogle Scholar
  30. Nancy NG, Mary PL (1984) Novel benzo[a]naphthacene quinones from an actinomycete, Frankia G-2 (ORS 020604). Can J Chem 62(12):2818–2821View ArticleGoogle Scholar
  31. Pettit RK (2011) Small-molecule elicitation of microbial secondary metabolites. Microb Biotechnol 4(4):471–478. https://doi.org/10.1111/j.1751-7915.2010.00196.x View ArticlePubMedPubMed CentralGoogle Scholar
  32. Rohr J, Thiericke R (1992) Angucycline group antibiotics. Nat Prod Rep 9(2):103–137View ArticleGoogle Scholar
  33. Romano S, Jackson SA, Patry S, Dobson ADW (2018) Extending the “One Strain Many Compounds” (OSMAC) principle to marine microorganisms. Mar Drugs. https://doi.org/10.3390/md16070244 View ArticlePubMedPubMed CentralGoogle Scholar
  34. Seyedsayamdost MR (2014) High-throughput platform for the discovery of elicitors of silent bacterial gene clusters. Proc Natl Acad Sci USA 111(20):7266–7271. https://doi.org/10.1073/pnas.1400019111 View ArticlePubMedGoogle Scholar
  35. Steverding D (2010) The development of drugs for treatment of sleeping sickness: a historical review. Parasit Vectors 3(1):15. https://doi.org/10.1186/1756-3305-3-15 View ArticlePubMedPubMed CentralGoogle Scholar
  36. Tawfike AF, Tate R, Abbott G, Young L, Viegelmann C, Schumacher M, Diederich M, Edrada-Ebel R (2017) Metabolomic tools to assess the chemistry and bioactivity of endophytic Aspergillus strain. Chem Biodivers. https://doi.org/10.1002/cbdv.201700040 View ArticlePubMedGoogle Scholar
  37. Van der Meij A, Worsley SF, Hutchings MI, van Wezel GP (2017) Chemical ecology of antibiotic production by actinomycetes. FEMS Microbiol Rev 41(3):392–416View ArticleGoogle Scholar
  38. Vicente J, Stewart AK, van Wagoner RM, Elliott E, Bourdelais AJ, Wright JL (2015) Monacyclinones, new angucyclinone metabolites isolated from Streptomyces sp. M7_15 associated with the puerto rican sponge Scopalina ruetzleri. Mar Drugs 13(8):4682–4700. https://doi.org/10.3390/md13084682 View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s) 2019

Advertisement